Viewing Study NCT06508216

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 11:49 AM
Ignite Modification Date: 2026-03-08 @ 11:44 PM
Study NCT ID: NCT06508216
Status: RECRUITING
Last Update Posted: 2024-07-22
First Post: 2024-07-03
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Explore Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of Novel Therapeutics in Patients With Early Relapsed Metastatic Triple-negative Breast Cancer
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None early relapsed metastatic View
None triple negative breast cancer View
None HER2 negative View
None Hormone-receptor negative breast cancer View